Galectin
Galectins are a class of proteins that bind specifically to
Structure
There are three different forms of galectin structure: dimeric, tandem or chimera. Dimeric galectins, also called prototypical galectins, are homodimers, consisting of two identical galectin subunits that have associated with one another. The galectins that fall under this category are galectin-1, -2, -5, -7, -10, -11, -14 and -15. Tandem galectins contain at least two distinct carbohydrate recognition domains (CRD) within one polypeptide, thus are considered intrinsically divalent. The CRDs are linked with a small peptide domain. Tandem galectins include galectin-4, -6, -8, -9 and -12. The final galectin is galectin-3 which is the only galectin found in the chimera category in vertebrates. Galectin-3 has one CRD and a long non-lectin domain. Galectin-3 can exist in monomeric form or can associate via the non-lectin domain into multivalent complexes up to a pentameric form.
The galectin carbohydrate recognition domain (CRD) is constructed from
Ligand binding
Galectins essentially bind to glycans featuring galactose and its derivatives. However, physiologically, they are likely to require lactose or N-acetyllactosamine for significantly strong binding. Generally, the longer the sugar the stronger the interactions. For example, galectin-9 binds to polylactosamine chains with stronger affinity than to an N-acetyllactosamine monomer. This is because more Van der Waals interactions can occur between sugar and binding pocket. Carbohydrate binding is calcium independent, unlike C-type lectins. The strength of ligand binding is determined by a number of factors: The multivalency of both of ligand and the galectin, the length of the carbohydrate and the mode of presentation of ligand to carbohydrate recognition domain. Different galectins have distinct binding specificities for binding
Function
Galectins are a large family with relatively broad specificity. Thus, they have a broad variety of functions including mediation of cell–cell interactions, cell–matrix
Apoptosis
Galectins are distinct in that they can regulate cell death both intracellularly and extracellularly. Extracellularly, they cross link glycans on the outside of cells and transduce signals across the membrane to directly cause cell death or activate downstream signaling that triggers apoptosis.[7] Intracellularly, they can directly regulate proteins that control cell fate. Many galectins have roles in apoptosis:
- One essential way galectins regulate apoptosis is to control CD45are involved in apoptosis.
- Galectin-7 is expressed under the
- Galectin-12 expression induces apoptosis of adipocytes.[8]
- Galectin-3 has been shown to be the only galectin with anti-apoptotic activity, proven by knock-out in mice increasing rates of apoptosis. Intracellularly, galectin-3 can associate with Bcl-2 proteins, an antiapoptotic family of proteins, and thus may enhance Bcl-2 binding to the target cell.[7] On the other hand, galectin-3 can also be pro-apoptotic and mediate T cell and neutrophil death.[8]
Suppression of T-cell receptor activation
Galectin-3 has an essential role in negatively regulating
Adhesion
Galectins can both promote and inhibit integrin-mediated adhesion. To enhance integrin-mediated adhesion, they cross link between two glycans on different cells. This brings the cells closer together so integrin binding occurs. They can also hinder adhesion by binding to two glycans on the same cell, which blocks the integrin[9] binding site. Galectin-8 is specific for the glycans bound to integrin and has a direct role in adhesion as well as activating integrin-specific signaling cascades.[10]
Nuclear pre-mRNA splicing
Galectin-1 and galectin-3 have been found, surprisingly, to associate with nuclear
Galectins in control of ESCRT, mTOR, AMPK, and autophagy
Cytoplasmic
The functional roles of galectins in cellular response to membrane damage are expanding, e.g. Galectin-3 recruits ESCRTs to damaged lysosomes so that lysosomes can be repaired.[15] This occurs before autophagy is induced to repair endosomes and lysosomes lest they are removed by autophagy.
Galectins and disease
Galectins are abundant, distributed widely around the body and have some distinct functions. It is because of these that they are often implicated in a wide range of diseases such as
Cancer
The best understood galectin in terms of cancer is galectin-3. Evidence suggests that galectin-3 plays a considerable part in processes linked to
Galectin-8, which increases integrin-mediated adhesion, has been shown to be downregulated in some cancers.[4] This benefits the cancer since integrin interactions with the extracellular matrix prevent metastasis. Lung cancer studies, however, have demonstrated increased adhesion to galectin-8 with increased metastatic potential, which may be mediated by elevated surface expression and activation of integrin α3β1.[17]
Intracellular pathogen invasion
Galectin-8 has been shown to play a specific role in assessing endosomal integrity. After pathogens, such as bacteria or viruses, are engulfed by cells, they typically try to exit the endosome to gain access to nutrients in the cytosol. Galectin-8 specifically binds to glycosylation found within the endosome, and recruits adapter molecule CALCOCO2 which activates antibacterial autophagy.[9] Galectin-3, galectin 8 and galectin-9 have been shown to play additional roles in autophagy both through control of mTOR (galectin-8) and AMPK (galectin-9),[13] and as a factor (galectin-3) in the assembly of the ULK1-Beclin 1-ATG16L1 initiator complex on TRIM16 during endomembrane damage.[14]
HIV
Galectin-1 has been shown to enhance HIV infection due to its galactose binding specificity. HIV preferentially infects
Chagas
Table of human galectins
Human galectin | Location | Function | Implication in disease |
---|---|---|---|
Galectin-1 | Secreted by immune cells such as by T helper cells in the thymus or by stromal cells surrounding B cells[8]
Also found in abundance in muscle, neurons and kidney[2] |
Negatively regulate B cell receptor activation
Activate apoptosis in T cells[7] Suppression of Th1 and Th17 immune responses[8] Contributes to nuclear splicing of pre-mRNA[24] |
Can enhance HIV infection
Found upregulated in tumour cells |
Galectin-2 | Gastrointestinal tract[25] | Binds selectively to β-galactosides of T cells to induce apoptosis[25] | Risk of myocardial infarction |
Galectin-3 | Wide distribution | Can be pro- or anti-apoptotic (cell dependent)
Regulation of some genes including JNK1[8] Contributes to nuclear splicing of pre-mRNA[24] Crosslinking and adhesive properties In the cytoplasm, helps form the ULK1-Beclin-1-ATG16L1-TRIM16 complex following endomembrane damage[14] |
Upregulation occurs in some cancers, including breast cancer, gives increased metastatic potential
Implicated in tuberculosis defense[14] |
Galectin-4 | Intestine and stomach | Binds with high affinity to lipid rafts suggesting a role in protein delivery to cells[8] |
Inflammatory bowel disease (IBD)[8] |
Galectin-7 | Stratified squamous epithelium[8] | Differentiation of keratinocytes
May have a role in apoptosis and cellular repair mediated by p53.[8] |
Implications in cancer Implications in psoriasis |
Galectin-8 | Wide distribution | Binds to integrins of the extracellular matrix.[4] In the cytoplasm, alternatively binds to mTOR or forms the GALTOR complex with SLC38A9, LAMTOR1, and RagA/B[13] | Downregulation in some cancers
Implicated in tuberculosis defense |
Galectin-9 | Kidney
Thymus[7] Macrophages |
Functions as a urate transporter in the kidney [26]
Induces apoptosis of thymocytes and Th1 cells[7][8] Enhances maturation of dendritic cells to secrete inflammatory cytokines. In the cytoplasm, associates upon lysosomal damage with AMPK and activates it[13] |
Rheumatoid arthritis
Implicated in tuberculosis defense[13][27] |
Galectin-10 |
Expressed in basophils
|
Essential role in immune system by suppression of T cell proliferation | Found in Charcot–Leyden crystals in asthma |
Galectin-12 | Adipose tissue | Stimulates apoptosis of adipocytes
Involved in adipocyte differentiation[8] |
None found |
Galectin-13 |
Placenta | Lysophospholipase | Pregnancy complications |
References
- ^ "Gene group: Galectins (LGALS)". HUGO Gene Nomenclarute Committee.
- ^ PMID 8063692.
- ^ a b
S2CID 5861095.
- ^ a b c d
Varki, A; Cummings, R.D.; Liu, F. (2009). "Chapter 33: Galectins". Essentials of Glycobiology (2nd ed.). Cold Spring Harbour (NY). PMID 20301264.
- S2CID 44347534.
- ^ ISBN 978-0-19-956911-3.
- ^ PMID 12244068.
- ^ S2CID 24193126.
- ^ PMID 22246324.
- S2CID 4953379.
- PMID 20574110.
- PMID 18662664.
- ^ PMID 29625033.
- ^ PMID 27693506.
- PMID 31813797.
- ^ S2CID 35482823.
- ^ PMID 23047680.
- ^ PMID 19690136.
- ^ S2CID 22981610.
- PMID 20816214.
- PMID 22064534.
- ^ PMID 25127057.
- ^ PMID 26451839. e0004148.
- ^ PMID 12223274.
- ^ PMID 15356130.
- PMID 11783481.
- PMID 20937702.
External links
- Galectin: Definition and History by Jun Hirabayashi
- Handbook of Animal Lectins by David Kilpatrick
- Galectin at the U.S. National Library of Medicine Medical Subject Headings (MeSH)